Instrument Inactif

Communiqués Neurotrope Inc Other OTC

Actions

US64129T1088

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

2020	Neurotrope, Inc. annonce ses résultats pour le troisième trimestre clos le 30 septembre 2020	CI
2020	Neurotrope, Inc. annonce ses résultats pour le deuxième trimestre clos le 30 juin 2020	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

NEUROTROPE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	25/11/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	24/11/20	AQ
NEUROTROPE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20/11/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	30/09/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	30/09/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/08/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	29/07/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	24/07/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	24/07/20	AQ
Neurotrope : Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute Trial for Childhood Leukemia	15/06/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/06/20	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Other Events (form 8-K)	28/05/20	AQ
Neurotrope : Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer’s Disease	28/05/20	PU
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	18/05/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	11/05/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	13/03/20	AQ
NEUROTROPE, INC. : Change in Directors or Principal Officers (form 8-K)	27/02/20	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	26/02/20	AQ
Neurotrope : Provides Corporate Update after Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's disease Trial	24/01/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Neurotrope Inc Other OTC

Actions

US64129T1088

Communiqués

Filtres